COMMUNIQUÉS West-GlobeNewswire

Teladoc Announces Second Quarter 2018 Results

01/08/2018 - 22:05

2Q 2018 Revenue of $94.6 million, growth of 112% Total Paid Membership of 22.5 million, growth of 48% 2Q 2018 Total Visits of 533,000, growth of 72% PURCHASE, NY, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Teladoc, Inc. (NYSE: [...]

Adverum Biotechnologies Announces Clinical Progress Across Gene Therapy Pipeline

01/08/2018 - 22:05

Dosed First Patient in Cohort 3 in the ADVANCE Phase 1/2 Trial of ADVM-043 Submitted Investigational New Drug (IND) Application for ADVM-022 Plans to submit an IND Application to the FDA for ADVM-053 in 4Q18 MENLO PARK [...]

K2M Group Holdings, Inc. Reports Second Quarter 2018 Financial Results and Updates Fiscal Year 2018 Outlook

01/08/2018 - 22:05

LEESBURG, Va., Aug. 01, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (Nasdaq:KTWO) (the “Company” or “K2M”), a global leader of complex spine and minimally invasive solutions focused on achieving three-dimensional [...]

Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock

01/08/2018 - 22:03

SAN DIEGO, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP), a specialty biopharmaceutical company primarily focused on developing and commercializing products in various therapeutic [...]

Spring Bank Pharmaceuticals Reports Second Quarter Financial Results

01/08/2018 - 22:01

Conference Call Scheduled for Thursday, August 2 at 8:00 a.m. EDT to Provide Corporate Update HOPKINTON, Mass., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage [...]

HTG Molecular Diagnostics to Present at Canaccord Genuity Growth Conference

01/08/2018 - 22:01

TUCSON, Ariz., Aug. 01, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced TJ Johnson, [...]

Aduro Biotech Reports Second Quarter 2018 Financial Results

01/08/2018 - 22:01

BERKELEY, Calif., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today reported financial results for the second quarter ended June 30, 2018. Net loss for the second quarter of 2018 was $24.4 [...]

Immune Design Reports Second Quarter 2018 Financial Results and Provides Corporate Update

01/08/2018 - 22:01

G100 advancing to late-stage development following FDA feedback Conference call at 1:30 pm Pacific today SEATTLE, WA and SOUTH SAN FRANCISCO, CA, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq: IMDZ), an [...]

BioCryst Pharmaceuticals Commences Public Offering of Common Stock

01/08/2018 - 22:01

RESEARCH TRIANGLE PARK, N.C., Aug. 01, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) a biotechnology company focused on the development and commercialization of treatments for rare and [...]

PRA Health Sciences, Inc. Reports Second Quarter 2018 Results and Updates Full Year 2018 Guidance

01/08/2018 - 22:00

Net new business of $670.0 million; Net book-to-bill of 1.30 $722.8 million of revenue; 35.4% growth at actual foreign exchange rates and 34.2% growth on a constant currency basis $575.0 million of revenue excluding the [...]

GOP Doctors Caucus Push to Penalize Small Practices Is Bad for Patients, States the Association of American Physicians and Surgeons (AAPS)

01/08/2018 - 20:36

TUCSON, Ariz., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Today, the Association of American Physicians and Surgeons (AAPS) asked GOP Doctors Caucus chairs, Rep. Phil Roe and Rep. Andy Harris, to rethink their support for [...]

NovuHealth Research Confirms that Engagement Drives Healthy Activities among Low-Income Consumers

01/08/2018 - 20:24

Data from a Medicaid Program in New York City Reveal that Targeted Plan Members Were 92% More Likely to Complete Healthy Activities MINNEAPOLIS, Aug. 01, 2018 (GLOBE NEWSWIRE) -- NovuHealth , the healthcare industry’s [...]

New study on advancing patient-reported outcome measures to increase patient-centered care

01/08/2018 - 19:00

Study appears in August 2018 issue of The Joint Commission Journal on Quality and Patient Safety OAKBROOK TERRACE, Ill., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Interest is growing in using patients’ own reports of their [...]

Lysogene Announces Upcoming Presentations at the 2018 International MPS symposium

01/08/2018 - 18:41

CAMBRIDGE, Mass. and PARIS, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Lysogene (FR0013233475 – LYS), a pioneering biopharmaceutical company specializing in gene therapy targeting central nervous system (CNS) diseases, today [...]

Tabula Rasa HealthCare Expands Medication Risk Mitigation Offerings to Western Europe

01/08/2018 - 18:00

MOORESTOWN, N.J., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc . (“TRHC”) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today announced it has entered into a [...]

NICOX : Number of voting rights as of July 31, 2018

01/08/2018 - 17:46

Nicox SA Société anonyme with a registered capital of € 29,588,510 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On August 1, 2018, MONTHLY PUBLICATION OF THE [...]

NICOX : Nombre de droits de vote au 31 juillet 2018

01/08/2018 - 17:46

Nicox SA Société anonyme au capital de 29 588 510 euros Siège social : DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 Le 1 août 2018, PUBLICATION MENSUELLE DU NOMBRE D'ACTIONS [...]

Lysogene Reports Second Quarter Cash Position and Provides Business and Strategic Update

01/08/2018 - 16:37

CAMBRIDGE, Mass. and PARIS, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Lysogene (FR0013233475 – LYS), a pioneering biopharmaceutical company specializing in gene therapy targeting central nervous system (CNS) diseases, today [...]

BioSig Technologies Files Application to Uplist to the NASDAQ

01/08/2018 - 15:32

Listing to Support Institutional Outreach Ahead of Commercialization Santa Monica, CA, Aug. 01, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. ( BSGM ), a medical device company developing a proprietary biomedical [...]